Healthcare & Life Sciences

Response Pharmaceuticals

aliveseries-a
series-a
Stage

About

Response Pharmaceuticals develops novel small molecule therapeutics focused on weight management and metabolic health, including treatments for antipsychotic-induced weight gain and management of weight after discontinuing GLP-1 receptor agonists.

Explore Response Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.